Comparative survival and time toxicity outcomes of CAR-T versus bispecific antibody therapies in relapsed/refractory FL. uri icon

authors

  • Major, Ajay
  • Wallace, Danielle S
  • Adhikari, Arjab
  • Patel, Dilan
  • Wanjiku, Christopher Mwaniki
  • Wagner, Charlotte B
  • Bock, Allison M
  • Brooks, Taylor R
  • Al Any, Haya
  • Mazie Tsang Tsang
  • Rajab, Mohamed
  • Abbott, Diana
  • Iqbal, Madiha
  • Desai, Nidhi
  • Gupta, Supriya
  • Altomare, Nicole
  • Karmali, Reem
  • Trotier, Daniel
  • Pophali, Priyanka A
  • Ricker, Edd
  • Cherng, Hua-Jay J
  • Chicola, Jessica A
  • Snyder, Jordan
  • Torka, Pallawi
  • Keenan, Jennifer C
  • Trabolsi, Asaad
  • Schatz, Jonathan H
  • Gupta, Arjun
  • Hill, Brian T
  • Ahmed, Nausheen
  • Nogueira Serodio, Alline
  • Villasboas, Jose Caetano
  • Sharp, John
  • Voorhees, Timothy J
  • Houshyar, Samin

publication date

  • October 30, 2026